A Double-Blind, Placebo-Controlled Proof-of-Concept Study Evaluating Therapy in Patients with Primary Biliary Cholangitis (PBC) Who Have an Inadequate Response or Are Intolerant of UDCA

November 27, 2018
https://clinicaltrials.gov/ct2/show/NCT03742973
Gastroenterology Hepatology
Principal Investigator: Stuart C Gordon, MD
PBC, pbc, primary biliary cholangitis, primary biliary cirrhosis,
Open
313-916-8423